Literature DB >> 9270488

Drug delivery to the brain.

W M Pardridge1.   

Abstract

Mesh：

Year:  1997        PMID： 9270488     DOI： 10.1097/00004647-199707000-00001

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN： 0271-678X            Impact factor:   6.200


× No keyword cloud information.
  66 in total

Review 1.  Functional expression and localization of P-glycoprotein in the central nervous system: relevance to the pathogenesis and treatment of neurological disorders.

Authors:  Gloria Lee; Reina Bendayan
Journal:  Pharm Res       Date:  2004-08       Impact factor: 4.200

Review 2.  The therapeutic potential of insulin-like growth factor-1 in central nervous system disorders.

Authors:  Jesse Costales; Alexander Kolevzon
Journal:  Neurosci Biobehav Rev       Date:  2016-01-15       Impact factor: 8.989

3.  Intracranial MEMS based temozolomide delivery in a 9L rat gliosarcoma model.

Authors:  Byron C Masi; Betty M Tyler; Hansen Bow; Robert T Wicks; Yuan Xue; Henry Brem; Robert Langer; Michael J Cima
Journal:  Biomaterials       Date:  2012-05-14       Impact factor: 12.479

Review 4.  Intranasal administration of neurotoxicants in animals: support for the olfactory vector hypothesis of Parkinson's disease.

Authors:  Rui D S Prediger; Aderbal S Aguiar; Filipe C Matheus; Roger Walz; Layal Antoury; Rita Raisman-Vozari; Richard L Doty
Journal:  Neurotox Res       Date:  2011-10-15       Impact factor: 3.911

5.  Potential gamma-hydroxybutyric acid (GHB) drug interactions through blood-brain barrier transport inhibition: a pharmacokinetic simulation-based evaluation.

Authors:  Indranil Bhattacharya; Kathleen M K Boje
Journal:  J Pharmacokinet Pharmacodyn       Date:  2006-08-29       Impact factor: 2.745

Review 6.  Manganese toxicity upon overexposure.

Authors:  Janelle Crossgrove; Wei Zheng
Journal:  NMR Biomed       Date:  2004-12       Impact factor: 4.044

Review 7.  Targeting the brain: rationalizing the novel methods of drug delivery to the central nervous system.

Authors:  Shailendra Joshi; Eugene Ornstein; Jeffrey N Bruce
Journal:  Neurocrit Care       Date:  2007       Impact factor: 3.210

8.  Galanin-induced decreases in nucleus accumbens/striatum excitatory postsynaptic potentials and morphine conditioned place preference require both galanin receptor 1 and galanin receptor 2.

Authors:  Emily B Einstein; Yukiko Asaka; Mark F Yeckel; Michael J Higley; Marina R Picciotto
Journal:  Eur J Neurosci       Date:  2013-02-07       Impact factor: 3.386

Review 9.  Convection-enhanced delivery for the treatment of pediatric neurologic disorders.

Authors:  Debbie K Song; Russell R Lonser
Journal:  J Child Neurol       Date:  2008-10       Impact factor: 1.987

10.  Convection-enhanced delivery of topotecan into diffuse intrinsic brainstem tumors in children.

Authors:  Richard C E Anderson; Benjamin Kennedy; Candix L Yanes; James Garvin; Michael Needle; Peter Canoll; Neil A Feldstein; Jeffrey N Bruce
Journal:  J Neurosurg Pediatr       Date:  2012-12-14       Impact factor: 2.375
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.